University of British Columbia Orders Canada's First Compact 850 MHz NMR System from Bruker to Enable Research on Microbial D...
15 December 2010 - 11:00PM
Business Wire
Bruker Corporation (NASDAQ: BRKR) announces a major order from
the University of British Columbia for its ultra-high field
AVANCE™ III 850 spectrometer. The 850 MHz Nuclear
Magnetic Resonance (NMR) magnet and spectrometer will enable
researchers at the University of British Columbia and nearby Simon
Fraser University to study the mechanisms of microbial diseases.
Funds to purchase Canada’s first 850 MHz actively-shielded
compact NMR magnet were provided to the ASTRID (Advanced Structural
Biology of Re-emerging Infectious Diseases) project by the Canada
Foundation for Innovation, the British Columbia Knowledge
Development Fund, and the University of British Columbia (UBC).
Bruker's new 850 MHz Ascend(TM) magnet
(Photo: Business Wire)
The AVANCE III 850 spectrometer is based on Bruker’s new
850 MHz Ascend™ magnet that combines the key advantages of
Bruker’s well-established UltraShield™ Plus magnets
with the superior performance and greater convenience delivered by
advanced superconductor technology. This further innovation has
enabled the design of smaller magnet coils, resulting in a
significant reduction in the size of the cryostat. The new Ascend
magnets are therefore easier to site, even safer to run and offer
reduced operating costs. With over 150 ultra-high field
installations worldwide, Bruker has an unmatched track record in
NMR magnet technology.
The AVANCE III 850 system includes Bruker’s
high-sensitivity CryoProbe™ technology, enabling researchers
to perform measurements on very small quantities of sample. In
addition it is equipped with Bruker’s latest Efree™ probe
technologies offering state-of-the-art research tools for the
investigation of membrane proteins in biological solid-state
NMR.
Suzana K. Straus, Associate Professor of Chemistry at UBC,
commented: “In recent years developments in the field of solid
state NMR have led to an emergence of biomolecular methods to
investigate membrane proteins. With this new magnet and probe
technology, we are now able to determine the full three-dimensional
structures and to characterize the membrane interactions of a range
of peptides and proteins of interest. This will have great impact
on our knowledge of infectious diseases.”
“The incredible sensitivity and dispersion of the
CryoProbe equipped solution and solid-state 850 MHz
spectrometer will enable ASTRID researchers to carry out
challenging structural and dynamic studies of the complex
biomolecular machines used by notorious pathogens, including
methicillin resistant Staphylococcus aureus, Pseudomonas
aeruginosa, and Mycobacterium tuberculosis,” said Lawrence
McIntosh, Professor of Biochemistry & Molecular Biology and
Chemistry at the University of British Columbia.
About Bruker Corporation
Bruker Corporation is a leading provider of high-performance
scientific instruments and solutions for molecular and materials
research, as well as for industrial and applied analysis. For more
information about Bruker Corporation, please visit
www.bruker.com.
For more information on Ascend magnets please visit
www.bruker.com/ascend
Photos/Multimedia Gallery Available:
http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6544677&lang=en
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024